Entry Detail



General Information

Database ID:exR0354662
RNA Name:hsa-miR-512-3p
RNA Type:miRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):53666729End Site(bp):53666750
External Links:hsa-miR-512-3p



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE93850
Description:Serum miRNAs in Patients with Glioblastoma Multiforme
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:22
Number of Control:8
Number of Samples:30





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
IFNAR1
chr21
33324429
33359864
+
RAI14
chr5
34656328
34832612
+
NAA16
chr13
41311267
41377030
+
TOB2
chr22
41433494
41446801
-
ASB1
chr2
238426742
238452250
+
RIT1
chr1
155897808
155911404
-
C9orf40
chr9
74946583
74952912
-
STK40
chr1
36339624
36385896
-
LETMD1
chr12
51047962
51060424
+
IQSEC1
chr3
12897043
13283281
-
COQ10B
chr2
197453423
197475308
+
ZCCHC3
chr20
297570
300321
+
FAM120AOS
chr9
93431441
93453581
-
NSD2
chr4
1871393
1982207
+
MTMR12
chr5
32226994
32312987
-
ZNF28
chr19
52797408
52857600
-
WASL
chr7
123681943
123749003
-
TOMM6
chr6
41787662
41789898
+
AP3M1
chr10
74120255
74151063
-
OCRL
chrX
129539849
129592561
+
SYVN1
chr11
65121780
65134533
-
LONP2
chr16
48244300
48363122
+
MID1IP1
chrX
38801432
38806537
+
SBF1
chr22
50445000
50475035
-
TNRC6A
chr16
24610209
24827632
+
RAB31
chr18
9708275
9862551
+
UHRF1BP1
chr6
34792015
34883138
+
ERMP1
chr9
5765076
5833117
-
ATP6V1E1
chr22
17592136
17628749
-
TRIB1
chr8
125430358
125438403
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001731
chr7
100731990
100738448
+
hsa_circ_0000384
chr12
27867712
27877119
+
hsa_circ_0001159
chr20
40161688
40179999
-
hsa_circ_0001865
chr9
86292641
86293514
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC091564.7
chr11
6610883
6616594
-
AC092718.4
chr16
81030770
81031485
+
FGD5-AS1
chr3
14920347
14948424
-
MIR497HG
chr17
7015818
7019659
-
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE93850
Sample Source:Blood
Source Fraction:Serum
Platform:GPL22948
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:1032
Sample treatment protocol:NA
RNA Extract protocol:Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada)
RNA library preparation protocol:0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.



Reference

PMID:28931080
Title:Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
Author:Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX
Journal:PLoS One. 2017 Sep 20;12(9):e0184969.
Description:we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.